Skip to content
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025
The year in biotech M&A activity got off to a promising start at ...
Read More
Medicare Part D plans are changing for 2025 – here’s what patients need to know
January brought important changes for the roughly 53 million seniors enrolled in Medicare ...
Read More
FTC’s second report on PBMs blasts drug price markups of 1,000%
Pharmacy benefit managers (PBMs) make billions in profit while driving up the price ...
Read More
BIO CEO urges innovation in access at White House CGT forum
As science progresses, we need parallel progress in making breakthrough treatments widely available, ...
Read More
Buzz around JPM Week partnering bodes well for biotech dealmaking, BIO says
The increased interest in JPM Week this year is an indication of an ...
Read More
USMCA dispute panel halts Mexico’s ban on biotech corn
A dispute panel ruled that Mexico’s planned ban on imports of biotech corn ...
Read More
EDITORS' CHOICE
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025
The year in biotech M&A activity got off to a promising start at JPM Week with announcements of some multi-billion-dollar deals. The flurry of networking ...
Read More
LATEST NEWS
BIO Events
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025
The year in biotech M&A activity got off to a promising start at JPM Week with announcements of some multi-billion-dollar deals. The flurry of networking ...
Health
Medicare Part D plans are changing for 2025 – here’s what patients need to know
January brought important changes for the roughly 53 million seniors enrolled in Medicare prescription drug plans. Some of these changes are automatic, while others require ...
Federal Policy
FTC’s second report on PBMs blasts drug price markups of 1,000%
Pharmacy benefit managers (PBMs) make billions in profit while driving up the price of prescription drugs with markups that can exceed 1,000%, according to a ...
Federal Policy
BIO CEO urges innovation in access at White House CGT forum
As science progresses, we need parallel progress in making breakthrough treatments widely available, BIO President & CEO John F. Crowley said at a Jan. 8 ...
BIO's View
Buzz around JPM Week partnering bodes well for biotech dealmaking, BIO says
The increased interest in JPM Week this year is an indication of an improved dealmaking environment for biotech, according to experts for the Biotechnology Innovation ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More
Federal Policy
State Policy
U.S. biotech generates $3.2 trillion in a year, report shows
The U.S. bioscience industry generated $3.2 trillion in overall output in 2023, according to the latest report from the Biotechnology Innovation Organization (BIO) and ...
Read More
International
Bio's View
Buzz around JPM Week partnering bodes well for biotech dealmaking, BIO says
The increased interest in JPM Week this year is an indication of an improved dealmaking environment for biotech, according to ...
Read More
